| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2006 | WO2006101663A1 Composition and method for modulating hydrogen ion physiology |
| 09/28/2006 | WO2006101603A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | WO2006101540A1 Reduction of postoperative pain medication |
| 09/28/2006 | WO2006101538A2 Andrographolide derivatives to treat viral infections |
| 09/28/2006 | WO2006101535A1 Inhibition of proteasome function to potentiate the proapoptotic and antitumor activity of cytokines |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006101455A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | WO2006101454A1 Benzothiophene derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | WO2006101434A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS |
| 09/28/2006 | WO2006101422A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | WO2006101407A1 Injection formulation containing the elements selenium and iodine |
| 09/28/2006 | WO2006101321A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 09/28/2006 | WO2006101318A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 09/28/2006 | WO2006101307A1 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent |
| 09/28/2006 | WO2006101273A1 Prophylactic/therapeutic agent for cancer |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006101244A2 Method and composition for treating mucosal disorders |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006101119A1 Collagen synthesis promoter |
| 09/28/2006 | WO2006101118A1 Application of d-psicose to suppression of abnormal circadian increase in blood glucose level |
| 09/28/2006 | WO2006101108A1 Novel cyclic aminophenylalkanoic acid derivative |
| 09/28/2006 | WO2006101105A1 Agent for treatment of psoriasis |
| 09/28/2006 | WO2006101104A1 Agent for treatment of arthritis |
| 09/28/2006 | WO2006101103A1 Agent for treatment of hematopoietic tumor |
| 09/28/2006 | WO2006101102A1 Agent for treatment of solid tumor |
| 09/28/2006 | WO2006101073A1 Anti-cancer agent and bacterium capable of producing novel compound prunustatin |
| 09/28/2006 | WO2006101062A1 Process for producing carbapenem derivative having 1-alkylpyrrolidine structure |
| 09/28/2006 | WO2006101052A1 Novel acetylene derivative |
| 09/28/2006 | WO2006101000A1 Anti-dermatan sulfate antibody and functional sulfated oligosaccharide |
| 09/28/2006 | WO2006100922A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | WO2006100875A1 Pharmaceutical composition |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006100710A1 Preventive or therapeutic composition for severe acute respiratory syndrome |
| 09/28/2006 | WO2006100692A2 A novel inter and intra multilamellar vesicular composition. |
| 09/28/2006 | WO2006100691A2 A process for the preparation of 6-o-methyl erythromycin a derivative |
| 09/28/2006 | WO2006100687A1 Disodium pamidronate aqueous formulation |
| 09/28/2006 | WO2006100686A1 Novel polymorph form g of fluvastatin sodium and process for the preparation thereof |
| 09/28/2006 | WO2006100647A1 Hydrogels for the controlled release of bioactive materials |
| 09/28/2006 | WO2006100633A1 NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-l-PHOSPHATE-1 RECEPTOR AGONISTS |
| 09/28/2006 | WO2006100631A1 Hydrogenated benzo (c) thiophene derivatives as immunomodulators |
| 09/28/2006 | WO2006100602A2 Immediate release stable solid oral dosage forms op fosinopril |
| 09/28/2006 | WO2006100591A1 4-piperazinnylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 09/28/2006 | WO2006100588A1 Substituted triazole derivatives as oxytocin antagonists |
| 09/28/2006 | WO2006100574A1 Amorphous cefditoren pivoxil granules and processes for the preparation thereof |
| 09/28/2006 | WO2006100563A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide |
| 09/28/2006 | WO2006100557A1 Substituted triazole derivatives as oxytocin antagonists |
| 09/28/2006 | WO2006100552A1 Processes for the preparation of lopinavir and its intermediate - (s)-tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetic acid |
| 09/28/2006 | WO2006100527A1 Effervescent tablet containing sodium alendronate and related use and process |
| 09/28/2006 | WO2006100520A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 09/28/2006 | WO2006100519A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | WO2006100485A1 A topical composition and its uses |
| 09/28/2006 | WO2006100468A1 Treatment of laminitis |
| 09/28/2006 | WO2006100461A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY |
| 09/28/2006 | WO2006100453A1 Glycopyrronium salts and their therapeutic use |
| 09/28/2006 | WO2006100439A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/28/2006 | WO2006100413A2 Novel compounds derived from 5-thioxylose and therapeutic use thereof |
| 09/28/2006 | WO2006100392A1 Novel use of tritoqualine for treating digestive inflammatory diseases and more particularly gastric and esophageal diseases |
| 09/28/2006 | WO2006100310A1 Heterobicylic inhibitors of hcv |
| 09/28/2006 | WO2006100285A1 Use of vitamin d compounds to treat endometriosis |
| 09/28/2006 | WO2006100255A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
| 09/28/2006 | WO2006100254A1 6-thioamide substituted benzimidazoles |
| 09/28/2006 | WO2006100251A1 Transdermal patch |
| 09/28/2006 | WO2006100243A1 Process for the preparation of pantoprazole |
| 09/28/2006 | WO2006100225A2 Benzoic acid ester compounds, compositions, uses and methods related thereto |
| 09/28/2006 | WO2006100213A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | WO2006100212A1 Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use |
| 09/28/2006 | WO2006100208A1 1-benzylindole-2-carboxamide derivatives |
| 09/28/2006 | WO2006100204A1 Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis |
| 09/28/2006 | WO2006100195A1 Use of macrolides for treating intestinal inflammation |
| 09/28/2006 | WO2006100181A2 New salt and polymorphs of a dpp-iv inhibitor |
| 09/28/2006 | WO2006100168A1 Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives |
| 09/28/2006 | WO2006100156A2 Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide |
| 09/28/2006 | WO2006100119A1 Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases |
| 09/28/2006 | WO2006100106A1 3-carboxy pyrroles as anti-viral agents |
| 09/28/2006 | WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 09/28/2006 | WO2006100095A1 Substituted carboxamides method for production and use thereof as tnf-alpha release inhibitors |
| 09/28/2006 | WO2006100081A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | WO2006100080A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | WO2006100026A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
| 09/28/2006 | WO2006100019A1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| 09/28/2006 | WO2006100017A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| 09/28/2006 | WO2006099978A1 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
| 09/28/2006 | WO2006099974A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 09/28/2006 | WO2006099972A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 09/28/2006 | WO2006099968A1 Metabolites for nk-i antagonists for emesis |
| 09/28/2006 | WO2006099958A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage |
| 09/28/2006 | WO2006099946A1 Transdermal therapeutic system |
| 09/28/2006 | WO2006099943A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments |
| 09/28/2006 | WO2006099941A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments |
| 09/28/2006 | WO2006099940A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 09/28/2006 | WO2006099884A1 Beta-aminoalcohol antibiotics |
| 09/28/2006 | WO2006099877A1 Rectal and vaginal suppositories containing bioadhesive bromocriptine and poloxamer |
| 09/28/2006 | WO2006099865A2 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | WO2006099864A2 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | WO2006099862A1 Addition salts of tolperisone, processes for their preparation and use thereof |
| 09/28/2006 | WO2006099810A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof |
| 09/28/2006 | WO2006099735A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 09/28/2006 | WO2006099706A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |